Form 8-K · Current Report · Filed 2024-09-10
Centene Reaffirms 2024 EPS Guidance and Shifts Q4 Performance
On September 10, 2024, Centene Corporation reaffirmed its 2024 full year adjusted diluted EPS guidance of greater than $6.80.
- Filer
- Centene Corporation CNC · NYSE
- Filed
- Accession
- 0001071739-24-000170
- CIK
- 0001071739
- Signal
- Low impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
The company also reiterated a shift of 20 to 30 cents of adjusted diluted EPS from Q3 to Q4, projecting Q3 adjusted diluted EPS between $1.31 to $1.41 and the remainder in Q4. The Company remains encouraged by its progress in improving its Medicare Advantage stars program performance.
Items reported
Regulation FD Disclosure
Market reaction
Close before filing
$70.84
Next session
+3.7%
Since filing
-12.2%
Latest close
$62.22
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from CNC reporting the same item, with the next session's move:
About Centene Corporation
Centene Corporation is a diversified healthcare enterprise providing a comprehensive range of managed care services to government-sponsored healthcare programs. Specializing in serving uninsured and underinsured populations, Centene offers health plans, benefits management, and other related services. It operates through two primary segments: Managed Care and Specialty Services. The Managed Care segment provides health plan coverage to individuals through Medicaid, Medicare Advantage, and the Health Insurance Marketplace, impacting millions of lives across the United States. Meanwhile, the Specialty Services segment enhances healthcare quality and affordability through offerings such as pharmacy solutions, behavioral health, and optometry services. Founded in 1984 and headquartered in St. Louis, Missouri, Centene plays a significant role in the healthcare sector by addressing accessibility and cost challenges, thereby shaping market trends and influencing policy developments. As a major participant in the managed care industry, Centene is crucial for promoting coordinated care and improving health outcomes for vulnerable populations.
Never miss another CNC filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.